BIOMARKERS FOR EARLY TREATMENT RESPONSE TO BIOLOGICS IN TREATMENT OF RHEUMATOID ARTHRITIS.

被引:0
|
作者
Zhang, Lijun [1 ]
Zhang, Li [2 ]
Amur, Shashi [2 ]
Siegel, Jeff [3 ]
Ding, Xiao [4 ]
Lau, Olivia [4 ]
Rochester, George [4 ]
Tornoe, Christoffer W. [5 ]
Doddapaneni, Suresh [1 ]
Sahajwalla, Chandrahas [1 ]
Nallani, Srikanth C. [1 ]
机构
[1] Div Clin Pharmacol, Silver Spring, MD USA
[2] Genom Grp, Silver Spring, MD USA
[3] Div Anesthesia Analgesia & Rheumatol Prod, Silver Spring, MD USA
[4] Off Biostatist, Silver Spring, MD USA
[5] Food & Drug Adm, CDER, Div Pharmacometr, Silver Spring, MD USA
来源
JOURNAL OF CLINICAL PHARMACOLOGY | 2010年 / 50卷 / 09期
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
114
引用
下载
收藏
页码:1083 / 1083
页数:1
相关论文
共 50 条
  • [41] Remission in Early Rheumatoid Arthritis: Predicting Treatment Response
    Ma, Margaret H. Y.
    Ibrahim, Fowzia
    Walker, David
    Hassell, Andrew
    Choy, Ernest H.
    Kiely, Patrick D. W.
    Williams, Richard
    Walsh, David A.
    Young, Adam
    Scott, David L.
    JOURNAL OF RHEUMATOLOGY, 2012, 39 (03) : 470 - 475
  • [42] Response to the pneumococcal vaccine in patients with early rheumatoid arthritis.
    Visvanathan, S
    Weiss, R
    Keenan, G
    Baker, D
    Wagner, C
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S379 - S379
  • [43] MICRORNA EXPRESSION PROFILES AS BIOMARKERS FOR PREDICTION OF TREATMENT RESPONSE TO ADALIMUMAB IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS
    Krintel, S. B.
    Dehlendorff, C.
    Hetland, M. L.
    Horslev-Petersen, K.
    Andersen, K. K.
    Junker, P.
    Podenphant, J.
    Ellingsen, T.
    Ahlqvist, P.
    Lindegaard, H. M.
    Linauskas, A.
    Schlemmer, A.
    Dam, M. Y.
    Hansen, I.
    Horn, H. C.
    Jorgensen, A.
    Raun, J.
    Ammitzboll, C. G.
    Ostergaard, M.
    Stengaard-Pedersen, K.
    Johansen, J. S.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 584 - 584
  • [44] Biomarkers as a treatment guide in rheumatoid arthritis
    Takeuchi, Tsutomu
    CLINICAL IMMUNOLOGY, 2018, 186 : 59 - 62
  • [45] Using predicted disease outcome to provide differentiated treatment of early rheumatoid arthritis.
    De Vries-Bouwstra, JK
    le Cessie, S
    Allaart, CF
    Breedveld, FC
    Huizinga, TWJ
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S540 - S540
  • [46] Safety of DMARD combination therapy to single drug treatment in early rheumatoid arthritis.
    LeirisaloRepo, M
    Kautiainen, H
    ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 122 - 122
  • [47] Biologics-Based Therapy for the Treatment of Rheumatoid Arthritis
    Scott, D. L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 (01) : 30 - 43
  • [48] The use of biologics in the treatment of rheumatoid arthritis (RA) - Reply
    McQueen, F
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1997, 27 (05): : 608 - 608
  • [49] Cost-Effectiveness of Biologics in Early Rheumatoid Arthritis RESPONSE
    Boers, Maarten
    ANNALS OF INTERNAL MEDICINE, 2010, 152 (05) : 334 - 334
  • [50] Treatment of early rheumatoid arthritis
    Geletka, R
    St Clair, EW
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2003, 17 (05): : 791 - 809